ArticleParasites & vectors2025
Control of Aedes albopictus populations by silencing of the vesicular GABA transporter (vgat) and the vesicular monoamine transporter (vmat) genes using recombinant Chlorella shRNA.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAedes albopictus is a primary vector for the transmission of dengue fever. RNA interference (RNAi)-based biocidal technology represents an important alternative and complement to conventional chemically synthesized insecticides.
methodsChlorella vulgaris was used as a carrier organism for RNAi-mediated gene silencing of Ae. albopictus. Short hairpin RNA (shRNA) expression vectors targeting the vgat and vmat genes of Ae. albopictus were constructed and subsequently used to transform C. vulgaris. The shRNA-transformed Chlorella were then administered to Ae. albopictus larvae or incorporated into attractive toxic sugar baits (ATSB) for adult feeding. The effects of silencing the vgat and vmat genes on Ae. albopictus were then investigated.
resultsBoth vgat and vmat shRNA-recombinant Chlorella exhibited high lethality against Ae. albopictus larvae and adults. Conversely, shRNA-recombinant Chlorella ATSBs were found to have no lethal effects on non-target organisms, including Drosophila melanogaster, Megalurothrips usitatus, Messor structor, and Lithobates catesbeiana tadpoles. Together, these results confirm the specificity and safety of using shRNA-recombinant Chlorella as a mosquito-killing agent. The results of a semi-field trial demonstrate that recombinant Chlorella ATSB maintained high lethality against Ae. albopictus and significantly reduced the number of eggs laid by this species. Additional experiments revealed that knockdown of the vgat gene in Ae. albopictus resulted in reduced sleep duration, leg twitching, and impaired flight. Conversely, knockdown of the vmat gene increased sleep duration, impaired walking and flight, and induced insensitivity to light levels.
conclusionsRecombinant Chlorella expressing vgat and vmat shRNAs demonstrated strong lethality, high specificity, and good safety against both larval and adult Ae. albopictus. Oral delivery of shRNAs effectively knocked down mosquito target genes, providing a convenient approach for functional studies of mosquito genetics. Notably, this study is an important addition to the use of recombinant microalgae as a mosquito biocide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.